CID 136234633

Ansornitinib

Structural Information

Molecular Formula
C30H32N6O4
SMILES
CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=N5)C(=O)OC)O
InChI
InChI=1S/C30H32N6O4/c1-34-15-17-36(18-16-34)19-25(37)35(2)22-11-9-21(10-12-22)31-27(20-7-5-4-6-8-20)26-23-13-14-24(30(39)40-3)32-28(23)33-29(26)38/h4-14,38H,15-19H2,1-3H3,(H,32,33)
InChIKey
CIBINADBMIHXHZ-UHFFFAOYSA-N
Compound name
methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-pyrrolo[2,3-b]pyridine-6-carboxylate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

39
Patents

540.2485 Da
Monoisotopic Mass

3.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 541.25578 227.3
[M+Na]+ 563.23772 229.3
[M-H]- 539.24122 235.4
[M+NH4]+ 558.28232 227.5
[M+K]+ 579.21166 224.1
[M+H-H2O]+ 523.24576 213.7
[M+HCOO]- 585.24670 239.9
[M+CH3COO]- 599.26235 231.7
[M+Na-2H]- 561.22317 224.9
[M]+ 540.24795 226.6
[M]- 540.24905 226.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe